| Mogamulizumab studied in …STUDIED_INderived33 of 33show fewer |
|---|
| → studied in | NCT06285370Phase 4 · completed A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy · 33 trials list this drug (9 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04930653Phase 2 · recruiting Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma · 33 trials list this drug (9 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Sezary Syndrome,Mycosis Fungoides and Sezary Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04256018Phase 2 · recruiting Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome · 33 trials list this drug (9 active) | — | — | Mycosis Fungoides,Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05455931completed Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER) · 33 trials list this drug (9 active) | — | — | Mycosis Fungoides and Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05414500Phase 1 · suspended Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides · 33 trials list this drug (9 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05956041Phase 2 · recruiting Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas · 33 trials list this drug (9 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05996185Phase 2 · recruiting Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma · 33 trials list this drug (9 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529405Phase 2 · not yet recruiting A Study of VG712 in Patients With Mycosis Fungoides · 33 trials list this drug (9 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06698003Phase 2 · recruiting A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1 · 33 trials list this drug (9 active) | — | — | Lymphoma,Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06235281early Phase 1 · suspended Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) · 33 trials list this drug (9 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04848064Phase 1 · recruiting Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma · 33 trials list this drug (9 active) | — | — | Adult T-Cell Leukemia/Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04541017Phase 1/Phase 2 · terminated Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment · 33 trials list this drug (9 active) | — | — | Mycosis Fungoides,Sezary Syndrome,Mycosis Fungoides and Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07132567recruiting Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance · 33 trials list this drug (9 active) | — | — | Mycosis Fungoides,Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02358473Phase 1 · completed Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer · 33 trials list this drug (9 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04676087Phase 1/Phase 2 · terminated Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides · 33 trials list this drug (9 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Mycosis Fungoides,Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00888927Phase 1/Phase 2 · completed Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma · 33 trials list this drug (9 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01226472Phase 2 · completed Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001 · 33 trials list this drug (9 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01626664Phase 2 · completed KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) · 33 trials list this drug (9 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01728805Phase 3 · completed Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL · 33 trials list this drug (9 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02301130Phase 1 · completed Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors · 33 trials list this drug (9 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867007Phase 1 · completed KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors · 33 trials list this drug (9 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04745234Phase 2 · unknown Mogamulizumab Q4week Dosing in Participants With R/R CTCL · 33 trials list this drug (9 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04128072Phase 2 · recruiting Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma · 33 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03309878Phase 1/Phase 2 · completed Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma · 33 trials list this drug (9 active) | — | — | Transformed B-Cell Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma,High Grade B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04185220Phase 1 · completed Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome · 33 trials list this drug (9 active) | — | — | Adult T-Cell Leukemia/Lymphoma,Mycosis Fungoides,Sezary Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02281409Phase 1/Phase 2 · completed Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors · 33 trials list this drug (9 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02946671Phase 1 · completed Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients · 33 trials list this drug (9 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm,Malignant Lip and Oral Cavity Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02444793Phase 1 · terminated A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors · 33 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01173887Phase 2 · completed Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 · 33 trials list this drug (9 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00920790Phase 2 · completed Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma · 33 trials list this drug (9 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01192984Phase 2 · completed Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma · 33 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01929486Phase 1 · unknown Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer. · 33 trials list this drug (9 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00355472Phase 1 · completed Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL · 33 trials list this drug (9 active) | — | — | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |